Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYNew microbes and new infections

A case of infection with a candidate new subtype, tentatively termed M, of human immunodeficiency virus type 1 of group M.

6 affiliations
  1. 1IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, Marseille, 13005, France.
  2. 2Assistance Publique-Hôpitaux de Marseille (AP-HM), Laboratoire des Agents Infectieux, 19-21 boulevard Jean Moulin, Marseille, 13005, France.
  3. 3Aix-Marseille Univ., Microbes Evolution PHylogeny and Infections (MEPHI), UR D-258, 27 boulevard Jean Moulin, Marseille, 13005, France.
  4. 4Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital La Timone, Laboratoire de Pharmacocinétique et Toxicologie, Marseille, France.
  5. 5Assistance Publique-Hôpitaux de Marseille (AP-HM), Service de Maladies Infectieuses, 19-21 boulevard Jean Moulin, Marseille, 13005, France.
  6. 6Aix-Marseille Univ., Risques Infectieux Tropicaux Microorganismes ÉmergentS (RITMES), D257_UMR MD4, 27 boulevard Jean Moulin, Marseille, 13005, France.

Abstract

Background

HIV-1 emergence is estimated to have occurred c.a. 1920s in the Democratic Republic of the Congo (DRC). Only its group M is pandemic. It currently comprises 10 established subtypes. Here, we describe a near-complete HIV-1 genome that meets the definition of a candidate new subtype.Methods

In-house-designed or commercial PCR primers were used for amplification of HIV-1 DNA from blood. Sequencing used Sanger and next-generation (Oxford Nanopore, Illumina) technologies. Bioinformatic analyses used Samtools, Minimap2, Viroscore, Bootscan, IQ-TREE, iTOL, MEGA12, and Nextclade. Structural analyses used Mutate, HyperChem, and Molegro Molecular Viewer.Results

The patient originates from the DRC. CD4⁺ T cell counts fluctuated between 351 and 2394/mm3, and plasma viral load, initially 5.0 log₁₀copies/mL, reached undetectability on antiretroviral therapy. The obtained near-full length genome (PZ307881) showed a mean nucleotide divergence of 12.7% (range, 11.9-13.7%) with genomes of the 10 established subtypes, while mean divergence was 12.6% (10.0-13.7%) between these 10 subtypes. Phylogeny displayed a star-like tree topology. No recombination was identified. No natural antiretroviral drug resistance was detected. Reverse transcriptase (RT) structure exhibited slight changes compared to subtype B RT that could alter processivity and may favor increased genetic diversity.Conclusions

These data support a candidate new HIV-1 group M subtype we tentatively termed M pending official taxonomic classification. They indicate that HIV-1 diversity is still not comprehensively deciphered and are in line with the DRC as an epicenter of the HIV-1/M pandemic. They warrant further studies to establish this provisional candidate new subtype by detecting it in other epidemiologically unlinked individuals, and to assess its epidemiological, genotypic and phenotypic features.

Related

  1. Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infection
    Maanasa Kaza, Benjamin Varco-Merth, G.W. McElfresh +17
    Cell ReportsPeer-reviewedCC BY-NC-ND 4.0MicrobiologyCrossref
  2. Why are some neurons spared in neurodegeneration? Cellular subtype identity maintenance as a candidate threshold-setting mechanism
    Dong Won Kim
    PLOS BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyPLOSDOAJ
  3. Refractory Pseudomonas aeruginosa Bronchopulmonary Infection After Lung Transplantation for Common Variable Immunodeficiency Despite Maximal Treatment Including IgM/IgA-Enriched Immunoglobulins and Bacteriophage Therapy
    Manon Levêque, Nadim Cassir, Fanny Mathias +7
    Infection and Drug ResistancePeer-reviewedCC BY-NCFull text15 citedImmunologyHAL
  4. Performance of point‐of‐care tests for diagnosing feline immunodeficiency virus infection in captive African lions ( Panthera leo )
    SE Jobbins, ME Westman, K Vinette Herrin +3
    Australian Veterinary JournalPeer-reviewedCC BY 4.0Full textZoology & animal behaviourPMC
  5. PERSISTENT OVERT DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH OPPORTUNISTIC CO-INFECTION BY DISSEMINATED HISTOPLASMOSIS AND CYTOMEGALOVIRUS DISEASE IN NEWLY DIAGNOSED HUMAN IMMUNODEFICIENCY VIRUS INFECTION: A RARE CASE REPORT
    Diego Alcântara SANTOS, Ana Carolina De Almeida MILAGRES, Lucas De Barros ANASTÁCIO
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textMicrobiologyDOAJ
BibTeX
@article{colson2026case,
  title = {{A case of infection with a candidate new subtype, tentatively termed M, of human immunodeficiency virus type 1 of group M.}},
  author = {Philippe Colson and Céline Boschi and Marielle Bedotto and Anne Motte and Caroline Solas and Marine Lefebvre and Matthieu Million and Christelle Tomei and Jeremy Delerce and Jacques Fantini},
  journal = {New microbes and new infections},
  year = {2026},
  month = oct,
  doi = {10.1016/j.nmni.2026.101863},
  url = {https://europepmc.org/article/MED/42927089},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - A case of infection with a candidate new subtype, tentatively termed M, of human immunodeficiency virus type 1 of group M.
AU  - Philippe Colson
AU  - Céline Boschi
AU  - Marielle Bedotto
AU  - Anne Motte
AU  - Caroline Solas
AU  - Marine Lefebvre
AU  - Matthieu Million
AU  - Christelle Tomei
AU  - Jeremy Delerce
AU  - Jacques Fantini
PY  - 2026
DA  - 2026/10/09
JO  - New microbes and new infections
DO  - 10.1016/j.nmni.2026.101863
UR  - https://europepmc.org/article/MED/42927089
AB  - Background  HIV-1 emergence is estimated to have occurred c.a. 1920s in the Democratic Republic of the Congo (DRC). Only its group M is pandemic. It currently comprises 10 established subtypes. Here, we describe a near-complete HIV-1 genome that meets the definition of a candidate new subtype.Methods  In-house-designed or commercial PCR primers were used for amplification of HIV-1 DNA from blood. Sequencing used Sanger and next-generation (Oxford Nanopore, Illumina) technologies. Bioinformatic analyses used Samtools, Minimap2, Viroscore, Bootscan, IQ-TREE, iTOL, MEGA12, and Nextclade. Structural analyses used Mutate, HyperChem, and Molegro Molecular Viewer.Results  The patient originates from the DRC. CD4⁺ T cell counts fluctuated between 351 and 2394/mm3, and plasma viral load, initially 5.0 log₁₀copies/mL, reached undetectability on antiretroviral therapy. The obtained near-full length genome (PZ307881) showed a mean nucleotide divergence of 12.7% (range, 11.9-13.7%) with genomes of the 10 established subtypes, while mean divergence was 12.6% (10.0-13.7%) between these 10 subtypes. Phylogeny displayed a star-like tree topology. No recombination was identified. No natural antiretroviral drug resistance was detected. Reverse transcriptase (RT) structure exhibited slight changes compared to subtype B RT that could alter processivity and may favor increased genetic diversity.Conclusions  These data support a candidate new HIV-1 group M subtype we tentatively termed M pending official taxonomic classification. They indicate that HIV-1 diversity is still not comprehensively deciphered and are in line with the DRC as an epicenter of the HIV-1/M pandemic. They warrant further studies to establish this provisional candidate new subtype by detecting it in other epidemiologically unlinked individuals, and to assess its epidemiological, genotypic and phenotypic features.
SN  - 2052-2975
ER  -